MediLink Therapeutics
Series BMar 2022

Series BMediLink Therapeutics

Overview

Funding Type

Series B

Announced Date

Money Raised

Sign up to unlock funding details

Create a free account — 10 credits a month to unlock amounts, dates, and investors.

About MediLink Therapeutics

Antibody Drug Conjugates
Oncology

Suzhou, China

View Full Profile